Immune Imbalances in Nonalcoholic Fatty Liver Disease: from General Biomarkers and Neutrophils, to Interleukin-17 Axis Activation, and New Therapeutics Targets

Immune Imbalances in Nonalcoholic Fatty Liver Disease: from General Biomarkers and Neutrophils, to Interleukin-17 Axis Activation, and New Therapeutics Targets

Nonalcoholic fatty liver disease (NAFLD) is an increasing problem worldwide and is associated with negative outcomes such as cirrhosis, hepatocellular carcinoma, insulin resistance, diabetes, and cardiovascular events. Current evidence shows that the immune response has an important participation dr...

Full description

Bibliographic Details
Main Author:	FELICIANO CHANANA PAQUISSI
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Series:	Frontiers in Immunology
Subjects:	Interleukin-17 Th17 Cells nonalcoholic fatty liver disease Treg cells Neutrophil to lymphocyte ratio Nonalcoholic steatohepatitis (NASH)
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00490/full

Similar Items

The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice
by: Beihui He, et al.
Published: (2017-06-01)

The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
by: Feliciano Chanana Paquissi, et al.
Published: (2021-09-01)

Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis
by: Feliciano Chanana Paquissi
Published: (2017-09-01)

Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota
by: Shuying He, et al.
Published: (2022-04-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
by: Ye Eun Cho, et al.
Published: (2023-10-01)

MicroRNA-29c Acting on FOS Plays a Significant Role in Nonalcoholic Steatohepatitis Through the Interleukin-17 Signaling Pathway
by: Chao Cai, et al.
Published: (2021-04-01)

Th17/Treg Imbalance in Chronic Obstructive Pulmonary Disease: Clinical and Experimental Evidence
by: Juliana Dias Lourenço, et al.
Published: (2021-12-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

Th17/Regulatory T-Cell Imbalance and Acute Kidney Injury in Patients with Sepsis
by: Xiao Zhou, et al.
Published: (2022-07-01)

Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases
by: Rony Thomas, et al.
Published: (2023-03-01)

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021-12-01)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
by: Martha D. Gay, et al.
Published: (2022-02-01)

Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
by: Chaoyang Wang, et al.
Published: (2023-10-01)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
by: Alessandro Mantovani, et al.
Published: (2020-12-01)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
by: Sadatsugu Sakane, et al.
Published: (2021-01-01)

A simple method for inducing nonalcoholic steatohepatitis with fibrosis
by: Leyla Yahaghi, et al.
Published: (2019-12-01)

The immunomodulation role of Th17 and Treg in renal transplantation
by: Dan-Lei Huang, et al.
Published: (2023-02-01)

Angiogenic effects of leptin in patients with nonalcoholic steatohepatitis
by: Gaafar Nagah, et al.
Published: (2005-01-01)

Involvement of the Autophagy-ER Stress Axis in High Fat/Carbohydrate Diet-Induced Nonalcoholic Fatty Liver Disease
by: Xiu Zhou, et al.
Published: (2020-08-01)

The Role of Interleukin-23 in Stability of In Vitro T Helper-17 Cells
by: Marjan Taherian, et al.
Published: (2014-04-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

Synovial IL-9 facilitates neutrophil survival, function and differentiation of Th17 cells in rheumatoid arthritis
by: Kaustav Chowdhury, et al.
Published: (2018-01-01)

Nonobese mice with nonalcoholic steatohepatitis fed on a choline‐deficient, l‐amino acid‐defined, high‐fat diet exhibit alterations in signaling pathways
by: Noriko Suzuki‐Kemuriyama, et al.
Published: (2021-11-01)

Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations
by: CM Oneta
Published: (2002-09-01)

Disease Progression in a Patient with Nonalcoholic Steatohepatitis
by: Ping-Huei Tseng, et al.
Published: (2008-10-01)

Effects of Th17 and Treg cells with their balance on thyroid-associated ophthalmopathy
by: Ping Wang, et al.
Published: (2022-07-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Interactions between neutrophils and T-helper 17 cells
by: Xinzou Fan, et al.
Published: (2023-10-01)

Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review
by: Tessa Kennedy-Martin, et al.
Published: (2018-06-01)

Recent research trends and updates on nonalcoholic fatty liver disease
by: Jeong-Ju Yoo, et al.
Published: (2019-03-01)

The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models
by: Zilong Wang, et al.
Published: (2024-02-01)

Croatian guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease
by: Lucija Virović Jukić, et al.
Published: (2021-01-01)

Relationship between Th17-mediated immunity and airway inflammation in childhood neutrophilic asthma
by: Qing Wei, et al.
Published: (2021-01-01)

Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives
by: Farhad Seif, et al.
Published: (2023-03-01)

Possible Development of Burn-Out Nonalcoholic Steatohepatitis under Long-Term Steroid Use
by: Soichiro Ota, et al.
Published: (2022-09-01)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013-08-01)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
by: Eleftheria Galatou, et al.
Published: (2022-05-01)

Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
by: Makiko Yajima, et al.
Published: (2019-03-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)